Stay updated with breaking news from Evolution Venture Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Combined company will operate as GRI Bio, Inc. and advance innovative pipeline of Natural Killer T modulating therapies for the treatment of inflammatory, fibrotic and autoimmune diseasesInvestment... | April 21, 2023
Leading BioSciences and Seneca Biopharma Announce Merger GERMANTOWN, Md. and CARLSBAD, Calif., Dec. 17, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA) ("Seneca"), and Leading BioSciences, Inc. ("LBS"), a privately held company focused on developing novel therapeutics to improve human health through therapeutic protection of the gastrointestinal ("GI") mucosal barrier, announced today that they have entered into a definitive agreement under which a wholly owned subsidiary of Seneca will merge with LBS in an all-stock transaction. The combined company will focus on advancing LBS's l...